A comparison between oral chemotherapy combined with radiotherapy and radiotherapy for newly diagnosed glioblastoma: A systematic review and meta-analysis

Medicine
Zhuo WangLi-Hua Dong

Abstract

The prognosis of glioblastoma (GBM), a major subtype of grade IV glioma, is rather poor nowadays. The efficiency of chemotherapy serving as the adjunct to radiotherapy (RT) for treating GBM is still controversial. In this study, we aim to investigate the overall survival (OS) and progression-free survival (PFS) in patients with newly diagnosed GBM received RT plus chemotherapy or with RT alone.Literatures were searched from the PubMed, Embase, and Cochrane Library between January 2001 and June 2015. Study selection was conducted based on the following criteria: randomized clinical trial (RCT) of adjuvant RT plus chemotherapy versus RT alone; studies comparing OS and/or PFS; and studies including cases medically confirmed of newly diagnosed GBM.Five RCTs (1655 patients) were eligible in this study. The meta-analysis showed a significant improvement in OS of patients treated with RT plus oral chemotherapy compared with that of RT alone (hazard ratio 0.70; 95% confidence interval, 0.56-0.88, P = .002).Adjuvant chemotherapy confers a survival benefit in patients newly diagnosed with GBM.

References

Dec 1, 1989·Journal of Neurosurgery·M S MahaleyB B Peace
Jan 1, 1996·Clinical & Experimental Metastasis·J S RaoR E Sawaya
Oct 17, 1998·Journal of the National Cancer Institute·J G CairncrossD N Louis
Dec 16, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H S FriedmanP L Modrich
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W K YungV A Levin
Mar 29, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D OsobaM Prados
Jan 11, 2001·The New England Journal of Medicine·L M DeAngelis
Apr 13, 2001·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M BradaS Zaknoen
Mar 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Roger StuppSerge Leyvraz
Mar 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Morris D GrovesVictor A Levin
Apr 23, 2003·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Rolf-Dieter KortmannMichael Bamberg
Jul 2, 2003·Nature Reviews. Cancer·Jasti S Rao
Feb 3, 2005·JAMA : the Journal of the American Medical Association·Paul Graham Fisher, Patricia A Buffler
Mar 11, 2005·The New England Journal of Medicine·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Mar 11, 2005·The New England Journal of Medicine·Monika E HegiRoger Stupp
Apr 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Helen AthanassiouPantelis Karageorgis
Apr 2, 2005·Nature Reviews. Cancer·Michael DeanSusan Bates
Jul 22, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Marta BrellFrancesc Graus
Mar 10, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David A ReardonDarell D Bigner
Jun 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·UNKNOWN Intergroup Radiation Therapy Oncology Group Trial 9402Walter Curran
Oct 10, 2006·Critical Reviews in Oncology/hematology·Malika L SikerMinesh P Mehta
Aug 2, 2008·The New England Journal of Medicine·Patrick Y Wen, Santosh Kesari
Nov 19, 2008·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Martin KocherRolf-Peter Müller
May 8, 2013·Neurologia i neurochirurgia polska·Dariusz SzczepanekTomasz Trojanowski

❮ Previous
Next ❯

Citations

Aug 14, 2018·Journal of Drug Targeting·Feng YuYanyu Xiao
May 1, 2020·Cancer Immunology, Immunotherapy : CII·J H AzambujaE Braganhol
Sep 8, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Jun-Man HongYoung-Il Hwang

❮ Previous
Next ❯

Software Mentioned

Review Manager

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.